SCHEMBL18598232

SCHEMBL18598232

C=C(CCCC)CCCCCO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
TSHR P16473 4/20 0.57
LMNA P02545 2/20 0.57
HSD17B10 Q99714 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 1/20 0.41
GPR84 Q9NQS5 4/20 0.39
CES2 O00748 3/20 0.39
CES1 P23141 3/20 0.39
FFAR1 O14842 2/20 0.39
FFAR4 Q5NUL3 2/20 0.39
PPARG P37231 5/20 0.37
PPARD Q03181 5/20 0.37
PPARA Q07869 5/20 0.37
HDAC11 Q96DB2 4/20 0.37
TLR2 O60603 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
FABP4 P15090 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23673050 1.00 ALDH1A1 (0.57) ALDH1A1TSHRLMNAHSD17B10MEN1
SCHEMBL11661288 0.87 CES2 (0.50) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL22711767 0.87 CES2 (0.50) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL19235427 0.87 CES2 (0.50) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL11002247 0.87 CES2 (0.50) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL22711836 0.87 CES2 (0.50) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL22712119 0.87 CES2 (0.50) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL22711608 0.87 CES2 (0.50) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL11658729 0.87 CES2 (0.50) ALDH1A1TSHRHSD17B10MEN1KMT2A
SCHEMBL2141578 0.87 CES2 (0.50) ALDH1A1TSHRHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138838-A1 SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS Dana-Farber Cancer Institute, Inc. (US) 2017-03-08 EP disclosed